You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

 

Online download statistics by month:

Online download statistics by month: January 2018 to September 2024

AbstractFullPdf
Jan 201819519429
Feb 201821120581
Mar 201827828279
Apr 201817617761
May 201812012338
Jun 201813113235
Jul 201812012028
Aug 201811911932
Sep 2018959534
Oct 201814314330
Nov 201812312339
Dec 201814514526
Jan 201913813726
Feb 201912612422
Mar 201911110741
Apr 2019908546
May 2019595920
Jun 2019615832
Jul 2019373526
Aug 2019342710
Sep 2019211713
Oct 2019424219
Nov 2019373632
Dec 2019656231
Jan 2020404025
Feb 2020443818
Mar 2020393711
Apr 202027258
May 2020343111
Jun 2020242310
Jul 2020242312
Aug 202018188
Sep 202035358
Oct 2020555410
Nov 2020363012
Dec 2020343315
Jan 2021353315
Feb 2021312811
Mar 202139397
Apr 2021363513
May 202171709
Jun 2021484611
Jul 202125239
Aug 202139379
Sep 2021383219
Oct 2021272727
Nov 2021201415
Dec 202120186
Jan 202217198
Feb 2022303216
Mar 2022403917
Apr 2022615524
May 2022413911
Jun 2022484517
Jul 2022262612
Aug 2022626012
Sep 2022434214
Oct 2022454213
Nov 2022474317
Dec 202219187
Jan 2023333520
Feb 202331300
Mar 2023282917
Apr 2023131216
May 2023161511
Jun 202317167
Jul 202323229
Aug 2023292913
Sep 202330307
Oct 202317167
Nov 2023413918
Dec 202318183
Jan 202419193
Feb 202421166
Mar 202434347
Apr 202443416
May 202422206
Jun 2024302511
Jul 202426248
Aug 202423173
Sep 2024998
Total451843921483